← Back to Search

Behavioural Intervention

OMT Protocol for Type 2 Diabetes

N/A

Waitlist Available

Led By Sonia Rivera-Martinez, DO

Research Sponsored by New York Institute of Technology

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test whether osteopathic manipulative therapy can help improve blood sugar levels for people with type 2 diabetes. Half the participants will receive real therapy, and half will receive a sham therapy.

Eligible Conditions

Type 2 Diabetes
Osteopathy

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Fasting glucose

Secondary outcome measures

A1C

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: OMT ProtocolExperimental Treatment1 Intervention

Subjects assigned to this arm will have selected osteopathic manipulative treatment techniques administered during the treatment sessions

Group II: OMT-Sham ProtocolPlacebo Group1 Intervention

Subjects assigned to this arm will have sham-osteopathic manipulative treatment techniques administered during the treatment sessions

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

New York Institute of TechnologyLead Sponsor

51 Previous Clinical Trials

1,971 Total Patients Enrolled

American Osteopathic AssociationOTHER

19 Previous Clinical Trials

3,565 Total Patients Enrolled

Sonia Rivera-Martinez, DOPrincipal InvestigatorNew York Institute of Technology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to take part in this experiment?

"Evidently, this clinical trial is still open to new participants - the posting was first published on November 15th 2018 and recent updates were made available April 25th 2022."

Answered by AI

Am I eligible to participate in this experiment?

"In order to qualify for this trial, applicants must have diabetes mellitus type 2 and be between the ages of 30 and 90. This clinical research is seeking approximately one hundred participants."

Answered by AI

Does the research embrace individuals of advanced age?

"Individuals aged between 30 and 90 years may join this trial."

Answered by AI

How many individuals have been accepted to this experiment so far?

"Affirmative. Clinicaltrials.gov lists this trial as actively looking for participants, which were first mentioned on November 15th 2018. As of April 25th 2022, the study is still in need of 100 patients from 2 sites."

Answered by AI

Recent research and studies

New England Journal of MedicineJournal

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

“Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin”. 2002. “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa012512.

The LancetJournal

Sustained Reduction in the Incidence of Type 2 Diabetes by Lifestyle Intervention: Follow-up of the Finnish Diabetes Prevention Study

Lindström, Jaana, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, et al.. 2006. “Sustained Reduction in the Incidence of Type 2 Diabetes by Lifestyle Intervention: Follow-up of the Finnish Diabetes Prevention Study”. The Lancet. Elsevier BV. doi:10.1016/s0140-6736(06)69701-8.

Osteopathic Medicine and Primary CareJournal

Rediscovering the Classic Osteopathic Literature to Advance Contemporary Patient-oriented Research: A New Look at Diabetes Mellitus

Licciardone, John C. 2008. “Rediscovering the Classic Osteopathic Literature to Advance Contemporary Patient-oriented Research: A New Look at Diabetes Mellitus”. Osteopathic Medicine and Primary Care. Springer Science and Business Media LLC. doi:10.1186/1750-4732-2-9.

Journal of Osteopathic MedicineJournal